Target intelligence / Profile preview

Protein synthesis stimulation

01

Overview

Protein synthesis stimulation refers to the acceleration of cellular protein production, typically via enhanced initiation and elongation of translation. This process is most commonly regulated through the mechanistic target of rapamycin complex 1 (mTORC1) signaling cascade, which integrates physiological signals from nutrients (notably amino acids), hormones, exercise, and stress to control translation machinery. Upregulation of protein synthesis can drive cell growth, muscle hypertrophy, and tissue repair but may also contribute to pathological states such as cancer when dysregulated. Protein synthesis stimulation is not a single molecular target, but instead describes a phenotype arising from the modulation of well-defined molecular effectors—most notably mTOR, eukaryotic translation initiation factors (eIFs), and various signaling kinases[1][2][3][9][6]. Because "Protein synthesis stimulation" is a process, not a molecule or receptor, it cannot serve as a canonical drug target and does not have a standard nomenclature, abbreviation, or classification like defined protein targets.

Other names
Protein synthesis activationStimulation of protein synthesisEnhanced protein biosynthesis
02

Mechanism of action

Activation of the mTORC1 pathway, leading to increased translation initiation and elongation Stimulation of the Akt pathway Relief of inhibition by translational repressors (e.g. eIF4EBPs) Enhanced ribosome assembly and activity

03

Biological functions

Cell growthMuscle hypertrophyResponse to nutrients and hormonesGeneral metabolism regulationProtein turnover
04

Disease associations

Muscle wasting (e.g. cachexia, sarcopenia)Some cancersMetabolic diseasesRecovery from injuryOther states involving altered protein metabolism
05

Safety considerations

Excessive protein synthesis can promote tumor growthRisk of metabolic disturbancesOrgan or tissue hypertrophy leading to dysfunction (e.g. cardiac hypertrophy)
06

Interacting drugs

Anabolic steroids (e.g. nandrolone)

4 more in the full profile.

07

Biomarkers

Phosphorylated S6 ribosomal proteinPhosphorylated 4EBP1Puromycin incorporation (SUnSET assay)Increased levels of newly synthesized proteins

Beyond the preview

Go deeper on Protein synthesis stimulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein synthesis stimulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call